Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032714 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Brunella Grassiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Ionic Liquids, Anti-Infective Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pisa.
Abstract (Originalsprache)
The therapeutic efficacy of topically administered drugs, however powerful, is largely affected by their bioavailability and, thus, ultimately, on their aqueous solubility and stability. The aim of this study was to evaluate the use of ionic liquids (ILs) as functional excipients to solubilise, stabilise, and prolong the ocular residence time of diacerein (DIA) in eye drop formulations. DIA is a poorly soluble and unstable anthraquinone prodrug, rapidly hydrolysed to rhein (Rhe), for the treatment of osteoarthritis. DIA has recently been evaluated as an antimicrobial agent for bacterial keratitis. Two ILs based on natural zwitterionic compounds were investigated: L-carnitine C6 alkyl ester bromide (Carn6), and betaine C6 alkyl ester bromide (Bet6). The stabilising, solubilising, and mucoadhesive properties of ILs were investigated, as well as their cytotoxicity to the murine fibroblast BALB/3T3 clone A31 cell line. Two IL–DIA-based eye drop formulations were prepared, and their efficacy against both Staphylococcus aureus and Pseudomonas aeruginosa was determined. Finally, the eye drops were administered in vivo on New Zealand albino rabbits, testing their tolerability as well as their elimination and degradation kinetics. Both Bet6 and Carn6 have good potential as functional excipients, showing solubilising, stabilising, mucoadhesive, and antimicrobial properties; their in vitro cytotoxicity and in vivo ocular tolerability pave the way for their future use in ophthalmic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
- Centre for Instrument Sharing of University of Pisa (CISUP), 56126 Pisa, Italy.
- Research Centre for Nutraceutical and Healthy Foods "NUTRAFOOD", University of Pisa, 56124 Pisa, Italy.
ORCID-Profile: Brunella Grassiri, Andrea Mezzetta, Angela Fabiano, Semih Esin, Lorenzo Guazzelli, Ylenia Zambito, Giovanna Batoni, Anna Maria Piras
Förderung
- University of Pisa
Zitieren
APA
Grassiri, B., Mezzetta, A., Maisetta, G., Migone, C., Fabiano, A., Esin, S., Guazzelli, L., Zambito, Y., Batoni, G., & Piras, A. M. (2023). Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032714
Vancouver
Grassiri B, Mezzetta A, Maisetta G, Migone C, Fabiano A, Esin S, et al. Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032714
BibTeX
@article{Grassiri2023,
author = {Grassiri, Brunella and Mezzetta, Andrea and Maisetta, Giuseppantionio and Migone, Chiara and Fabiano, Angela and Esin, Semih and Guazzelli, Lorenzo and Zambito, Ylenia and Batoni, Giovanna and Piras, Anna Maria},
title = {Betaine- and L-Carnitine-Based Ionic Liquids as Solubilising and Stabilising Agents for the Formulation of Antimicrobial Eye Drops Containing Diacerein},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032714}
}
EUVIMED